Killian K J
Department of Medicine, McMaster University, Hamilton, Ont.
Clin Invest Med. 2001 Apr;24(2):110-7.
This 55-year-old man with known rheumatic mitral valve disease is modestly disabled achieving a VO2max of 72% and a maximal power output of 76% of the predicted normal. His capacity to exercise is limited by dyspnea due to a reduction in his capacity to breathe. Ipratropium bromide was initiated to maximize his expiratory flow and improve his ventilatory capacity. A trial of inhaled steroids produced no improvement. He was referred for rehabilitation and smoking cessation. A decision was made to continue surveillance, postponing mitral valve replacement.
这位55岁的男性患有风湿性二尖瓣疾病,功能有一定程度受限,其最大摄氧量为预测正常值的72%,最大功率输出为预测正常值的76%。他的运动能力因呼吸能力下降导致的呼吸困难而受限。开始使用异丙托溴铵以最大化其呼气流量并改善通气能力。吸入性类固醇试验未带来改善。他被转介进行康复治疗并戒烟。决定继续监测,推迟二尖瓣置换手术。